Prelude Therapeutics Inc 10-K for FY2024
Prelude Therapeutics Inc (PRLD)
10-K
2025-03-10
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 10-K
Prelude Therapeutics Inc filed this 10-K on March 10, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $7M
- Net loss
- $127.17M
- compared with a net loss of $121.83M a year earlier
- Diluted EPS
- -$1.68
- compared with -$2.02 a year earlier